Sep 4 |
J&J owes over $1B in damages related to 2019 Auris deal, judge rules
|
Sep 4 |
Judge rules J&J owes Auris investors $1 billion related to 2019 robotics deal
|
Sep 4 |
3 Dividend Stocks to Double Up on Right Now
|
Sep 4 |
Is Johnson & Johnson (JNJ) the Best Cancer Stock to Buy Now?
|
Sep 3 |
Johnson & Johnson (JNJ): Among ChatGPT’s Recent Stock Recommendations
|
Sep 2 |
Johnson & Johnson (JNJ): A Good 52-Week High Stock to Buy According to Short Sellers
|
Sep 2 |
Johnson & Johnson picks Onco360 as pharmacy partner for LAZCLUZE
|
Sep 1 |
These Four Dividend Kings Could Thrive Even If The Consumer Falters
|
Sep 1 |
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
|
Aug 31 |
Johnson & Johnson's (NYSE:JNJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
|